-
1
-
-
84929355556
-
-
Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose e. V 37. Informationsbericht. 2014; 108 125
-
(2014)
37. Informationsbericht
, pp. 108-125
-
-
-
2
-
-
84861124193
-
Phase II dose-ranging trial of the early bactericidal activity of PA-824
-
Diacon A. H., Dawson R., du Bois J. et al. Phase II dose-ranging trial of the early bactericidal activity of PA-824. Antimicrob Agents Chemother: 2012; 56 3027 3031
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 3027-3031
-
-
Diacon, A.H.1
Dawson, R.2
Du, B.J.3
-
3
-
-
84866177379
-
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: A randomised trial
-
Diacon A. H., Dawson R., von Groote-Bidlingmaier F. et al. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial. Lancet: 2012; 380 986 993
-
(2012)
Lancet
, vol.380
, pp. 986-993
-
-
Diacon, A.H.1
Dawson, R.2
Von Groote-Bidlingmaier, F.3
-
4
-
-
84929745288
-
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
-
Heinrich N., Dawson R., du Bois J. et al. Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients. J Antimicrob Chemother: 2015; 10.1093/jac/dku553
-
(2015)
J Antimicrob Chemother
-
-
Heinrich, N.1
Dawson, R.2
Du Bois, J.3
-
5
-
-
84899637134
-
Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis
-
Wallis R. S., Dawson R., Friedrich S. O. et al. Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis. PloS one: 2014; 9 e94462
-
(2014)
PloS One
, vol.9
, pp. e94462
-
-
Wallis, R.S.1
Dawson, R.2
Friedrich, S.O.3
-
6
-
-
19944429772
-
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
-
Andries K., Verhasselt P., Guillemont J. et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science: 2005; 307 223 227
-
(2005)
Science
, vol.307
, pp. 223-227
-
-
Andries, K.1
Verhasselt, P.2
Guillemont, J.3
-
7
-
-
35848948213
-
In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor
-
Huitric E., Verhasselt P., Andries K. et al. In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor. Antimicrob Agents Chemother: 2007; 51 4202 4204
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 4202-4204
-
-
Huitric, E.1
Verhasselt, P.2
Andries, K.3
-
8
-
-
48749120676
-
Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis
-
Rustomjee R., Diacon A. H., Allen J. et al. Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis. Antimicrob Agents Chemother: 2008; 52 2831 2835
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 2831-2835
-
-
Rustomjee, R.1
Diacon, A.H.2
Allen, J.3
-
9
-
-
66649090346
-
The diarylquinoline TMC207 for multidrug-resistant tuberculosis
-
Diacon A. H., Pym A., Grobusch M. et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med: 2009; 360 2397 2405
-
(2009)
N Engl J Med
, vol.360
, pp. 2397-2405
-
-
Diacon, A.H.1
Pym, A.2
Grobusch, M.3
-
10
-
-
84861140844
-
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: Long-term outcome, tolerability, and effect on emergence of drug resistance
-
Diacon A. H., Donald P. R., Pym A. et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrob Agents Chemother: 2012; 56 3271 3276
-
(2012)
Antimicrob Agents Chemother
, vol.56
, pp. 3271-3276
-
-
Diacon, A.H.1
Donald, P.R.2
Pym, A.3
-
11
-
-
84907377122
-
Multidrug-resistant tuberculosis and culture conversion with bedaquiline
-
Diacon A. H., Pym A., Grobusch M. P. et al. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med: 2014; 371 723 732
-
(2014)
N Engl J Med
, vol.371
, pp. 723-732
-
-
Diacon, A.H.1
Pym, A.2
Grobusch, M.P.3
-
13
-
-
33845947982
-
Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo 1 2 oxazoles
-
Sasaki H., Haraguchi Y., Itotani M. et al. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo 1 2 oxazoles. Journal of medicinal chemistry: 2006; 49 7854 7860
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, pp. 7854-7860
-
-
Sasaki, H.1
Haraguchi, Y.2
Itotani, M.3
-
14
-
-
33845323336
-
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
-
Matsumoto M., Hashizume H., Tomishige T. et al. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS medicine: 2006; 3 e466
-
(2006)
PLoS Medicine
, vol.3
, pp. e466
-
-
Matsumoto, M.1
Hashizume, H.2
Tomishige, T.3
-
16
-
-
79958718650
-
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
-
Diacon A. H., Dawson R., Hanekom M. et al. Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients. Int J Tuberc Lung Dis: 2011; 15 949 954
-
(2011)
Int J Tuberc Lung Dis
, vol.15
, pp. 949-954
-
-
Diacon, A.H.1
Dawson, R.2
Hanekom, M.3
-
17
-
-
84861864703
-
Delamanid for multidrug-resistant pulmonary tuberculosis
-
Gler M. T., Skripconoka V., Sanchez-Garavito E. et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med: 2012; 366 2151 2160
-
(2012)
N Engl J Med
, vol.366
, pp. 2151-2160
-
-
Gler, M.T.1
Skripconoka, V.2
Sanchez-Garavito, E.3
-
18
-
-
84878776777
-
Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
-
Skripconoka V., Danilovits M., Pehme L. et al. Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis. Eur Respir J: 2013; 41 1393 1400
-
(2013)
Eur Respir J
, vol.41
, pp. 1393-1400
-
-
Skripconoka, V.1
Danilovits, M.2
Pehme, L.3
|